References
1. Goodwin K, Viboud C, Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine. 2006;24(8):1159–69. 2. Lazuardi L, Jenewein B, Wolf AM, Pfister G, Tzankov A, GrubeckLoebenstein B. Age-related loss of naïve T cells and dysregulation of T-cell/B-cell interactions in human lymph nodes. Immunology. 2005;114(1):37–43. 3. Muszkat M, Friedman G, Dannenberg HD, Greenbaum E, Lipo M, Heymann Y, et al. Response to influenza vaccination in community and in nursing home residing elderly: relation to clinical factors. Exp Gerontol. 2003;38(10):1199–203. 4. Busse WW, Peters SP, Fenton MJ, Mitchell H, Bleecker ER, Castro M, et al. Vaccination of patients with mild and severe asthma with a 2009 pandemic H1N1 influenza virus vaccine. J Allergy Clin Immunol. 2011;127(1):130–7. 5. Kaml M, Weiskirchner I, Keller M, Luft T, Hoster E, Hasford J, et al. Booster vaccination in the elderly: their success depends on the vaccine type applied earlier in life as well as on pre-vaccination antibody titers. Vaccine. 2006;24(47-48):6808–11. 6. Nursyirwan SA, Koesnoe S, Wahyudi ER, Mansjoer A. Faktor-faktor prediktor serokonversi pasca-vaksinasi influenza pada lansia. JPDI. 2017;4(4):204-8. 7. Wahyudi ER, Dwimartutie N, Yasmine E. Vaksinasi pada usia lanjut. Dalam: Djauzi S, Rengganis I, Sundoro J, Koesnoe S, Soegiarto G, Maria S, editor. Pedoman imunisasi pada orang dewasa 2017. Jakarta: Interna Publishing; 2017. h.284-98.
Recommended Citation
Rengganis, Iris
(2017)
"Vaksinasi pada Lansia,"
Jurnal Penyakit Dalam Indonesia: Vol. 4:
Iss.
4, Article 1.
DOI: 10.7454/jpdi.v4i4.164
Available at:
https://scholarhub.ui.ac.id/jpdi/vol4/iss4/1
